欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2004, Vol. 9 ›› Issue (1): 104-106.

• 研究原著 • 上一篇    下一篇

倍他米松新霉素软膏治疗限局性亚急性湿疹的临床研究

毛越苹, 尹若菲, 曾凡钦, 林宝珠   

  1. 中山大学附属第二医院皮肤科, 广州 510120, 广东
  • 收稿日期:2003-05-20 修回日期:2003-06-18 出版日期:2004-01-26 发布日期:2020-11-16
  • 通讯作者: 毛越苹,女, 硕士, 主要从事皮肤病与性病学研究。Tel:020-81332077  E-mail: maoyp@163.com

Clinical study of betamethasone neomycin ointment in treatment of patients with subacute eczema

MAO Yue-Ping, YING Ruo-Fei, ZENG Fan-Qin, LIN Bao-Zhu   

  1. Department of Dermatology &Venerology, the Second Affiliated Hospital of Sun Yat-Sen University of Medical Sciences. Guangzhou 510120, Guangdong, China
  • Received:2003-05-20 Revised:2003-06-18 Online:2004-01-26 Published:2020-11-16

摘要: 目的: 评价倍他米松新霉素软膏治疗湿疹的疗效和安全性。方法: 选择限局性亚急性湿疹患者进行随机双盲、平行组对照临床试验研究, 选择新氢松软膏进行对照。结果: 共入选病例45 例, 其中试验组23 例, 对照组22 例。试验组用药后总积分由用药前12.3 ±2.4 下降至5.6 ±2.2(第1 wk) 和2.8±2.1(第2 wk), 明显优于对照组[13.2 ±2.3(用药前), 9.2 ±3.7(第1 wk), 6.8 ±3.5(第2 wk) ], 经秩和检验有显著性差异P<0.01);试验组总有效率86.96 %(20/23例), 高于对照组31.82 %(7/22例)(P<0.01) 。两组均无药物相关性局部及全身不良反应。结论: 倍他米松新霉素软膏外用治疗亚急性湿疹, 与新氢松软膏对照组比较, 总体疗效试验组明显优于对照组, 且耐受性好。

关键词: 倍他米松新霉素软膏, 新氢松软膏, 亚急性湿疹, 临床试验

Abstract: AIM: To evaluate the efficacy and the safety of betamethasone neomycin ointment in treatment of patients with subacute eczema.METHODS: The clinical trial was performed on patients with limited, subacute eczema by a randomized double-blind method.Hydrocortisone neomycin ointment was chosen as controls.RESULTS: There were 45 patients involved in this study, including 23 patients in betamethasone neomycin ointment group and 22 patients in hydrocortisone neomycin ointment group.The total integra decrease of betamethasone neomycin ointment group [12.26 ±2.42 to 5.61 ±2.23 (d 7), 2.83 ±2.06 (d 14) ] was better than that of hydrocortisone neomycin ointment group [13.18 ±2.28 to 9.18 ±3.72(d 7), 6.82 ±3.46(d 14) ] on the 7th and 14th day after the treatment (P<0.01).The total effective rate of betamethasone neomycin ointment group (86.96 %) was higher than that of hydrocortisone neomycin ointment group (31.82 %, P<0.01).Nether located nor systemic side effects were found in both groups.CONCLUSION: Betamethasone neomycin ointment is an effective and easily tolerated agent for treatment of subacute eczema compared with hydrocortisone neomycin ointment.

Key words: betamethasone neomycin ointment, hydrocortisone neomycin ointment, subacute eczema, clinical trials

中图分类号: